{"id":"feclemine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"licaran","offLabel":[],"synonyms":["feclemine","giacosil","licaran","phenetamine","phenethamine"],"timeline":[],"approvals":[],"brandName":"Licaran","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and FECLEMINE is a key that fits into those locks. When it binds to the right lock, it can turn on or off certain cellular processes to help treat a disease or condition. This is a simplified way of understanding how small molecule drugs like FECLEMINE work.","oneSentence":"FECLEMINE works by binding to specific proteins or receptors in the body to produce a therapeutic effect.","technicalDetail":"FECLEMINE is a small molecule that likely interacts with specific biological targets, such as enzymes, receptors, or ion channels, to produce its therapeutic effect. The exact mechanism of action is unknown, but it may involve modulation of signaling pathways or regulation of gene expression."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3744","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FECLEMINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:29:40.404281","biosimilars":[],"competitors":[],"genericName":"feclemine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"5P7U986QGO","CHEBI":"CHEBI:135518","INN_ID":"4505","UMLSCUI":"C1880739","ChEMBL_ID":"CHEMBL2106137","PUBCHEM_CID":"3030835"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FECLEMINE, also known as Licaran, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce a therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand this drug.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}